The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Prostacyclin: A Potent Antimetastatic Agent
Abstract
Metastasis is the principal cause of failures to cure human cancers. Prostacyclin is a powerful antimetastatic agent against B16 amelanotic melanoma cells. This effect, which may result from the platelet antiaggregatory action of prostacyclin, is potentiated by a phosphodiesterase inhibitor. Inhibitors of prostacyclin synthesis increase metastasis. Prostacyclin and agents that may increase endogenous prostacyclin production or prolong its activity are suggested as new antimetastatic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of cancer metastasis
Poste, G., & Fidler, I. J. (1980) · Nature · doi:10.1038/283139a0 · Cited by 1,739
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
Platelet—tumor‐cell interactions in mice. The role of platelets in the spread of malignant disease
Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T., & Murphy, S. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110322 · Cited by 452
Prostacyclin is a circulating hormone
MONCADA, S., KORBUT, R., BUNTING, S., & VANE, J. R. (1978) · Nature · doi:10.1038/273767a0 · Cited by 379
Lysosomal Cathepsin B: Correlation with Metastatic Potential
Sloane, B. F., Dunn, J. R., & Honn, K. V. (1981) · Science · doi:10.1126/science.7233209 · Cited by 367
Self-citationThe role of prostacyclin in vascular tissue.
Moncada, S., & Vane, J. R. (1979) · PubMed · Cited by 316
Salmon, J. A., Smith, D. R., Flower, R. J., et al. (1978) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(78)90028-1 · Cited by 304
Kramer, R. H., & Nicolson, G. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5704 · Cited by 267
Pearlstein, E., Salk, P. L., Yogeeswaran, G., & Karpatkin, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4336 · Cited by 192
Hawiger, J., Parkinson, S., & Timmons, S. (1980) · Nature · doi:10.1038/283195a0 · Cited by 188
Microangiopathic Haemolytic Anaemia and Mucin‐forming Adenocarcinoma
Brain, M. C., Azzopardi, J. G., Baker, L. R. I., Pineo, G. F., Roberts, P. D., & Dacie, J. V. (1970) · British Journal of Haematology · doi:10.1111/j.1365-2141.1970.tb01433.x · Cited by 149
Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
Hyman, A. L., & Kadowitz, P. J. (1979) · Circulation Research · doi:10.1161/01.res.45.3.404 · Cited by 87
Gasic, G. J., KOCH, P. A., Hsu, B., Gasic, T. B., & Niewiarowski, S. (1976) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00286945 · Cited by 82
Gastpar, H. (1977) · PubMed · Cited by 51
Cited by
Palumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Jirousková, M., & Degen, J. L. (2005) · Blood · doi:10.1182/blood-2004-06-2272 · Cited by 999
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.14 · Cited by 749
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., & Bugge, T. H. (2000) · Blood · doi:10.1182/blood.v96.10.3302 · Cited by 605
Wolfe, L. S. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb10847.x · Cited by 573
Battinelli, E. M., Markens, B. A., & Italiano, J. E. (2011) · Blood · doi:10.1182/blood-2011-02-334524 · Cited by 365
Metadata
- Authors
- Honn, K. V., Cicone, B., & Skoff, A.
- Venue
- Science
- Published
- 1981-06-12
- Volume
- 212
- Issue
- 4500
- Pages
- 1270-1272
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1981581994
- Cited by
- 331
- References
- 15
- FWCI
- 30.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.